Open AccessA Case Series of Lung Sequelae and Aspergillus Antigenemia- A Hidden Entity in Post-COVID-19 Critically ILL Patients
Author(s) -
Sonali Banwait,
Poonam Gupta
Publication year - 2021
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2021/48272.14902
Subject(s) - medicine , galactomannan , ards , aspergillosis , colistin , critically ill , intensive care medicine , acute respiratory distress , covid-19 , intensive care , antibiotics , pediatrics , lung , immunology , disease , infectious disease (medical specialty) , microbiology and biotechnology , biology
Coronavirus Disease-2019 Associated Invasive Aspergillosis (CAPA) is a known entity with significant mortality. There is paucity of literature with secondary aspergillosis infection in post-COVID-19 patients. Serum galactomannan is a highly sensitive test for screening patients for Aspergillus antigenemia. We report five post COVID-19 patients with High Resolution Computed Tomography (HRCT) features and associated high risk factors for opportunistic aspergillosis (55 years old male, 46 years old male, 75 years old female, 55 years old female and 27 years old male) like prolonged intensive care stay, acute respiratory distress syndrome, corticosteroid and broad spectrum antibiotic therapy like Meropenem, Colistin and Targocid etc.